Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,757.50
Bid: 1,757.50
Ask: 1,758.50
Change: 24.00 (1.38%)
Spread: 1.00 (0.057%)
Open: 1,736.00
High: 1,759.50
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

Wed, 09th Oct 2019 10:21

* FTSE 100 up 0.1%, FTSE 250 down 0.1%

* GVC gains after forecast upgrade

* Just Eat tops blue-chip risers

By Muvija M and Shashwat Awasthi

Oct 9 (Reuters) - London's exporter-laden FTSE 100 lagged
its European peers on Wednesday, as sterling gained on a report
that the EU was ready to make a "major concession" on the Brexit
divorce deal, while Just Eat helped the index hold on to slim
gains.

The blue-chip index, whose components make
two-thirds of their earnings abroad, was slightly off the day's
highs but was still up 0.1% by 0858 GMT, while the FTSE 250
was down 0.1%.

A report that the European bloc was ready to offer a
concession to the contested Irish backstop plan lifted the
pound, with exporter stocks clinging to gains made earlier in
the session when Brexit sentiment was unclear.

Shares in companies that earn a chunk of their earnings in
the U.S. dollar including GlaxoSmithKline and Reckitt
Benckiser were still offering the most support to the
main index.

Just Eat climbed 2% to top the FTSE 100 leader-board,
after its Dutch rival Takeaway.com reported a surge in
quarterly orders.

GVC outperformed the midcap index with a 3% rise as
the Ladbrokes owner boosted its annual core earnings target for
the second time in three months on robust demand in its betting
shops despite tighter regulation.

That news helped rival William Hill gain 1.5%.

Financials, which have been hammered this year
due to the Hong Kong protests and fears of a recession, rose
0.6%.

The sub-index has plunged 6% since the start of 2019,
severely lagging a near 7% rise in the FTSE 100 over the same
period and being the only major sector with year-to-date losses.

The recovery comes ahead of the release of minutes from the
U.S. Federal Reserve's last meeting scheduled later in the day,
which could provide further insight on the extent to which the
world's biggest central bank will venture out to support any
slowdown.

With Sino-U.S. talks set to resume tomorrow and as the
chaotic Brexit process drags on, investor sentiment has been on
the cautious side since the new quarter began.

Those concerns also kept a lid on Wednesday's rise.

"Though a trade war breakthrough seems a distant prospect,
there is always an element of unpredictably where Trump is
concerned," Spreadex analyst Connor Campbell said.

"The next few days, then, are going to be nothing if not
interesting."

(Reporting by Muvija M in Bengaluru; Editing by Bernard Orr)

More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.